The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $103.72

Today's change+0.21 +0.20%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $103.72

Today's change+0.21 +0.20%
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

USANA Health Sciences Inc up (U.S.)$0.21

USANA Health Sciences Inc closed up Friday by (U.S.)$0.21 or 0.20% to (U.S.)$103.72. Over the last five days, shares have gained 0.47% and 37.23% year to date. Shares have outperformed the S&P 500 by 22.20% during the last year.

Key company metrics

  • Open(U.S.) $104.13
  • Previous close(U.S.) $103.51
  • High(U.S.) $104.59
  • Low(U.S.) $102.65
  • Bid / Ask(U.S.) $85.00 / (U.S.) $0.00
  • YTD % change+37.23%
  • Volume78,717
  • Average volume (10-day)90,794
  • Average volume (1-month)139,955
  • Average volume (3-month)161,152
  • 52-week range(U.S.) $55.01 to (U.S.) $118.84
  • Beta1.28
  • Trailing P/E19.30×
  • P/E 1 year forward17.60×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.37
Updated December 26 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.10%

Based on its net profit margin of 10.10%, USANA Health Sciences Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.10%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Food Processing
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 27, 201409/27/2014Jun 28, 201406/28/2014Mar 29, 201403/29/2014Dec 28, 201312/28/2013
Revenue192188182186
Total other revenue--------
Total revenue192188182186
Gross profit157153149152
Total cost of revenue35353434
Total operating expense163159157157
Selling / general / administrative128124123123
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income29292529
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax29292529
Income after tax19191720
Income tax, total91099
Net income19191720
Total adjustments to net income--------
Net income before extra. items19191720
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items19191720
Inc. avail. to common incl. extra. items19191720
Diluted net income19191720
Dilution adjustment--00--
Diluted weighted average shares13141414
Diluted EPS excluding extraordinary itemsvalue per share1.471.351.151.41
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.471.351.151.41